These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33166618)
1. Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis. Kaur H; Kalia M; Taneja N Microb Pathog; 2021 Mar; 152():104608. PubMed ID: 33166618 [TBL] [Abstract][Full Text] [Related]
2. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis. Uddin R; Masood F; Azam SS; Wadood A Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846 [TBL] [Abstract][Full Text] [Related]
3. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799 [TBL] [Abstract][Full Text] [Related]
4. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB. Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799 [TBL] [Abstract][Full Text] [Related]
5. Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii. Ahmad S; Raza S; Uddin R; Azam SS J Mol Graph Model; 2018 Jun; 82():74-92. PubMed ID: 29705560 [TBL] [Abstract][Full Text] [Related]
6. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742 [TBL] [Abstract][Full Text] [Related]
7. Promising Tan YC; Lahiri C Front Immunol; 2022; 13():900509. PubMed ID: 35720310 [TBL] [Abstract][Full Text] [Related]
8. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays. Skariyachan S; Manjunath M; Bachappanavar N J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934 [TBL] [Abstract][Full Text] [Related]
9. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Solanki V; Tiwari V Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii. Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729 [No Abstract] [Full Text] [Related]
12. Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants. Liu F; Zhu Y; Yi Y; Lu N; Zhu B; Hu Y BMC Genomics; 2014 Dec; 15(1):1163. PubMed ID: 25534766 [TBL] [Abstract][Full Text] [Related]
13. Protein Therapeutic Target Candidates Against Swain A; Pan A OMICS; 2023 Feb; 27(2):62-74. PubMed ID: 36735546 [No Abstract] [Full Text] [Related]
15. Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202. Lee SY; Yun SH; Lee YG; Choi CW; Leem SH; Park EC; Kim GH; Lee JC; Kim SI J Antimicrob Chemother; 2014 Jun; 69(6):1483-91. PubMed ID: 24486871 [TBL] [Abstract][Full Text] [Related]
16. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii. Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808 [TBL] [Abstract][Full Text] [Related]
17. Polymyxin B Heteroresistance and Adaptive Resistance in Multidrug- and Extremely Drug-Resistant Acinetobacter baumannii. Genteluci GL; de Souza PA; Gomes DBC; Sousa VS; de Souza MJ; Abib JRL; de Castro EAR; Rangel K; Villas Bôas MHS Curr Microbiol; 2020 Sep; 77(9):2300-2306. PubMed ID: 32494882 [TBL] [Abstract][Full Text] [Related]
18. Genetic mechanisms of antibiotic resistance and virulence in Acinetobacter baumannii: background, challenges and future prospects. Chakravarty B Mol Biol Rep; 2020 May; 47(5):4037-4046. PubMed ID: 32303957 [TBL] [Abstract][Full Text] [Related]
19. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea. Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642 [TBL] [Abstract][Full Text] [Related]
20. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C mBio; 2019 Jul; 10(4):. PubMed ID: 31311879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]